skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Polycystic kidney disease: inheritance, pathophysiology, prognosis, and treatment

Review

(3979) Views  (2022) Full article downloads

Authors: Christian R Halvorson, Matthew S Bremmer, Stephen C Jacobs

Published Date June 2010 Volume 2010:3 Pages 69 - 83
DOI: http://dx.doi.org/10.2147/IJNRD.S6939

Christian R Halvorson1, Matthew S Bremmer1, Stephen C Jacobs1

1Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA

Abstract: Both autosomal dominant and recessive polycystic kidney disease are conditions with severe associated morbidity and mortality. Recent advances in the understanding of the genetic and molecular pathogenesis of both ADPKD and ARPKD have resulted in new, targeted therapies designed to disrupt cell signaling pathways responsible for the abnormal cell proliferation, dedifferentiation, apoptosis, and fluid secretion characteristic of the disease. Herein we review the current understanding of the pathophysiology of these conditions, as well as the current treatments derived from our understanding of the mechanisms of these diseases.

Keywords: Polycystic kidney disease, autosomal dominant, recessive, end stage renal disease








Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
The use of everolimus in renal-transplant patients
Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin
Nephrolithiasis-induced end stage renal disease
Health literacy and health seeking behavior among older men in a middle-income nation
Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients?
Update on the diagnosis and management of acute kidney injury
Erratum
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Emerging drug combinations to optimize renovascular protection and blood pressure goals
  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio